AstraZeneca to Invest $50 Billion in US Manufacturing
AstraZeneca recently announced $50 billion of investment in the US by 2030. This investment is expected to create tens of thousands of new, highly skilled jobs nationwide.
pharma manufacturing
Quality and Safety in Biopharmaceutical Production
The biopharmaceutical industry is experiencing a drive towards biologic products due to their promise as treatments for chronic diseases.
The Impact of Covid-19 on the Pharmaceutical Industry
Andrew Badrot, CEO of C2 Pharma and a close observer of pharma industry trends, analyzes the current situation and how this pandemic may kick of changes in the pharma market.
